| Mediastruction | 65.8 | 3 | 2 |
| Klaviyo | 60.0 | 24 | 0 |
| Ogilvy | 45.7 | 2 | 1 |
| iProspect | 45.7 | 2 | 1 |
| advertising agency | 40.0 | 0 | 2 |
| media agency | 40.0 | 0 | 2 |
| .monks | 40.0 | 0 | 2 |
| programmatic advertising | 40.0 | 0 | 2 |
| Regulatory compliance requirements for an open source electronic image trial management system | 40.0 | 0 | 2 |
| regulated sectors law | 40.0 | 0 | 2 |
| rumble | 40.0 | 0 | 2 |
| Adgeeks | 40.0 | 0 | 2 |
| Full-media service romanian agency | 40.0 | 0 | 2 |
| Al-Marwa Munir | 40.0 | 0 | 2 |
| Media buy loader, graphical user interface, and method of correlating media buys to customer intakes | 40.0 | 0 | 2 |
| Upraw Media | 40.0 | 0 | 2 |
| BBDO | 38.2 | 1 | 1 |
| McCann | 38.2 | 1 | 1 |
| A. Eicoff & Company | 38.2 | 1 | 1 |
| Jordan/Zalaznick Advisers Inc. | 36.3 | 6 | 0 |
| skai | 33.4 | 5 | 0 |
| Optimove | 25.8 | 3 | 0 |
| G2 | 25.8 | 3 | 0 |
| Republic TV | 25.8 | 3 | 0 |
| mass media | 25.2 | 0 | 1 |
| pay-per-click | 25.2 | 0 | 1 |
| ZenithOptimedia | 25.2 | 0 | 1 |
| Abbott Mead Vickers BBDO | 25.2 | 0 | 1 |
| Dentsu International | 25.2 | 0 | 1 |
| Annoncen-Expedition | 25.2 | 0 | 1 |
| online advertising | 25.2 | 0 | 1 |
| regulatory compliance | 25.2 | 0 | 1 |
| Investor relations | 25.2 | 0 | 1 |
| law review | 25.2 | 0 | 1 |
| waste treatment | 25.2 | 0 | 1 |
| Saatchi & Saatchi | 25.2 | 0 | 1 |
| media planning | 25.2 | 0 | 1 |
| FCB | 25.2 | 0 | 1 |
| digital marketing | 25.2 | 0 | 1 |
| EuroPress | 25.2 | 0 | 1 |
| Grey Global Group | 25.2 | 0 | 1 |
| Heinz Todtmann | 25.2 | 0 | 1 |
| Jung von Matt | 25.2 | 0 | 1 |
| J. Walter Thompson | 25.2 | 0 | 1 |
| TBWA Worldwide | 25.2 | 0 | 1 |
| Tradedoubler | 25.2 | 0 | 1 |
| Maxus | 25.2 | 0 | 1 |
| performance-based advertising | 25.2 | 0 | 1 |
| Scholz & Friends | 25.2 | 0 | 1 |
| Sotsu | 25.2 | 0 | 1 |
| Nijgh | 25.2 | 0 | 1 |
| Don Draper | 25.2 | 0 | 1 |
| Havas Creative | 25.2 | 0 | 1 |
| Benton & Bowles | 25.2 | 0 | 1 |
| Francine Van Hove | 25.2 | 0 | 1 |
| list of advertising agencies | 25.2 | 0 | 1 |
| Media Transports | 25.2 | 0 | 1 |
| Nurun | 25.2 | 0 | 1 |
| French advertising agency | 25.2 | 0 | 1 |
| Sylvio Perlstein | 25.2 | 0 | 1 |
| D'Arcy Masius Benton & Bowles | 25.2 | 0 | 1 |
| N. W. Ayer & Son | 25.2 | 0 | 1 |
| BIGWEST | 25.2 | 0 | 1 |
| AMIN Worldwide | 25.2 | 0 | 1 |
| Alinean | 25.2 | 0 | 1 |
| Ally & Gargano | 25.2 | 0 | 1 |
| Amalgamated Advertising | 25.2 | 0 | 1 |
| American Association of Advertising Agencies | 25.2 | 0 | 1 |
| Anomaly | 25.2 | 0 | 1 |
| Arnold Worldwide | 25.2 | 0 | 1 |
| Q4799719 | 25.2 | 0 | 1 |
| Ascentium | 25.2 | 0 | 1 |
| Barkley Inc. | 25.2 | 0 | 1 |
| Bartle Bogle Hegarty | 25.2 | 0 | 1 |
| Beta News Agency | 25.2 | 0 | 1 |
| Boase Massimi Pollitt | 25.2 | 0 | 1 |
| Broadcast calendar | 25.2 | 0 | 1 |
| Burrell Communications Group | 25.2 | 0 | 1 |
| Camp+King | 25.2 | 0 | 1 |
| Mithun Agency | 25.2 | 0 | 1 |
| Carlton Screen Advertising | 25.2 | 0 | 1 |
| Chango | 25.2 | 0 | 1 |
| Cheil Worldwide | 25.2 | 0 | 1 |
| Clare Barnes, Jr. | 25.2 | 0 | 1 |
| Collett Dickenson Pearce | 25.2 | 0 | 1 |
| Comparison of demand generation software | 25.2 | 0 | 1 |
| Compliance requirements | 25.2 | 0 | 1 |
| consent management | 25.2 | 0 | 1 |
| Contact Singapore | 25.2 | 0 | 1 |
| Cordiant Communications Group | 25.2 | 0 | 1 |
| Crawford's Advertising Agency | 25.2 | 0 | 1 |
| Crispin Porter + Bogusky | 25.2 | 0 | 1 |
| Cyber-Duck | 25.2 | 0 | 1 |
| DCF Advertising | 25.2 | 0 | 1 |
| DNA Studio | 25.2 | 0 | 1 |
| Dancer Fitzgerald Sample | 25.2 | 0 | 1 |
| Danish Defence Media Agency | 25.2 | 0 | 1 |
| decoupling | 25.2 | 0 | 1 |
| demand-side platform | 25.2 | 0 | 1 |
| demand generation | 25.2 | 0 | 1 |
| Dentsu iX Inc. | 25.2 | 0 | 1 |
| Doner Company | 25.2 | 0 | 1 |
| Door Number 3 | 25.2 | 0 | 1 |
| Droga5 | 25.2 | 0 | 1 |
| M&C Saatchi | 25.2 | 0 | 1 |
| Eloïne Barry | 25.2 | 0 | 1 |
| Fahlgren Mortine | 25.2 | 0 | 1 |
| Fallon Worldwide | 25.2 | 0 | 1 |
| Floxx | 25.2 | 0 | 1 |
| GMR Marketing | 25.2 | 0 | 1 |
| GSD&M | 25.2 | 0 | 1 |
| George Patterson Y&R | 25.2 | 0 | 1 |
| GlobalHue | 25.2 | 0 | 1 |
| Goodby, Silverstein & Partners | 25.2 | 0 | 1 |
| Gotham, Inc. | 25.2 | 0 | 1 |
| Grant McCann Erickson | 25.2 | 0 | 1 |
| Green Team | 25.2 | 0 | 1 |
| Guy Walks Into an Advertising Agency | 25.2 | 0 | 1 |
| HHCL | 25.2 | 0 | 1 |
| health marketing | 25.2 | 0 | 1 |
| Health network surveillance | 25.2 | 0 | 1 |
| storyboard artist | 25.2 | 0 | 1 |
| Johnstone and Cushing | 25.2 | 0 | 1 |
| Kaplan Thaler Group | 25.2 | 0 | 1 |
| Karmarama | 25.2 | 0 | 1 |
| KraftWorks | 25.2 | 0 | 1 |
| LatinWorks | 25.2 | 0 | 1 |
| Israel Government Advertising Agency | 25.2 | 0 | 1 |
| London Press Exchange | 25.2 | 0 | 1 |
| Luna\TBWA | 25.2 | 0 | 1 |
| Martin Williams Advertising | 25.2 | 0 | 1 |
| McKinney | 25.2 | 0 | 1 |
| Media buying | 25.2 | 0 | 1 |
| Medical education agency | 25.2 | 0 | 1 |
| Mekanism | 25.2 | 0 | 1 |
| Mojo | 25.2 | 0 | 1 |
| Mother | 25.2 | 0 | 1 |
| NKPR Inc | 25.2 | 0 | 1 |
| Neathawk Dubuque & Packett | 25.2 | 0 | 1 |
| Shalmor Avnon Amichay | 25.2 | 0 | 1 |
| News Agency of Nigeria | 25.2 | 0 | 1 |
| Norwegian Media Authority | 25.2 | 0 | 1 |
| Nuisance abatement | 25.2 | 0 | 1 |
| Organic, Inc. | 25.2 | 0 | 1 |
| PAMS | 25.2 | 0 | 1 |
| Papert Koenig Lois | 25.2 | 0 | 1 |
| Partners and Napier | 25.2 | 0 | 1 |
| Plan B Advertising Agency | 25.2 | 0 | 1 |
| Publicis & Hal Riney | 25.2 | 0 | 1 |
| R/GA | 25.2 | 0 | 1 |
| R/West | 25.2 | 0 | 1 |
| RPA | 25.2 | 0 | 1 |
| Round Table Advertising | 25.2 | 0 | 1 |
| S. H. Benson | 25.2 | 0 | 1 |
| SMART | 25.2 | 0 | 1 |
| Scali, McCabe, Sloves | 25.2 | 0 | 1 |
| Seeding agency | 25.2 | 0 | 1 |
| Seiter & Miller Advertising | 25.2 | 0 | 1 |
| Shoot | 25.2 | 0 | 1 |
| Siren interactive | 25.2 | 0 | 1 |
| Starcom IP Asia | 25.2 | 0 | 1 |
| Stuart Advertising Agency | 25.2 | 0 | 1 |
| Student-run advertising agency | 25.2 | 0 | 1 |
| Studio Total | 25.2 | 0 | 1 |
| Switch | 25.2 | 0 | 1 |
| TM Advertising | 25.2 | 0 | 1 |
| Ted Bates | 25.2 | 0 | 1 |
| the7stars | 25.2 | 0 | 1 |
| The Ant Farm | 25.2 | 0 | 1 |
| The Martin Agency | 25.2 | 0 | 1 |
| The Richards Group | 25.2 | 0 | 1 |
| Total Media Agency | 25.2 | 0 | 1 |
| Toth Brand Imaging | 25.2 | 0 | 1 |
| Traction | 25.2 | 0 | 1 |
| Trampoline | 25.2 | 0 | 1 |
| Vibe Australia | 25.2 | 0 | 1 |
| Video news release | 25.2 | 0 | 1 |
| Worldwide Partners | 25.2 | 0 | 1 |
| Category:Advertising agencies of Russia | 25.2 | 0 | 1 |
| Category:Advertising agencies of the United States | 25.2 | 0 | 1 |
| Category:Advertising agencies of Japan | 25.2 | 0 | 1 |
| Category:Advertising agencies by country | 25.2 | 0 | 1 |
| Category:Advertising agencies of Australia | 25.2 | 0 | 1 |
| Category:Advertising agencies of Canada | 25.2 | 0 | 1 |
| Category:Advertising agencies of France | 25.2 | 0 | 1 |
| Category:Advertising agencies of India | 25.2 | 0 | 1 |
| Category:Advertising agencies of Germany | 25.2 | 0 | 1 |
| Category:Advertising agencies of Finland | 25.2 | 0 | 1 |
| Category:Advertising agencies of Slovenia | 25.2 | 0 | 1 |
| Category:Advertising agencies of South Africa | 25.2 | 0 | 1 |
| Category:Advertising agencies of South Korea | 25.2 | 0 | 1 |
| Category:Advertising agencies of the Philippines | 25.2 | 0 | 1 |
| Category:Advertising agencies of Sweden | 25.2 | 0 | 1 |
| Category:Advertising agencies of the United Kingdom | 25.2 | 0 | 1 |
| Category:Advertising agencies | 25.2 | 0 | 1 |
| Category:Regulatory compliance | 25.2 | 0 | 1 |
| Artplan | 25.2 | 0 | 1 |
| DDB Stockholm | 25.2 | 0 | 1 |
| TBWA\Chiat\Day | 25.2 | 0 | 1 |
| Irving | 25.2 | 0 | 1 |
| Performance Marketing | 25.2 | 0 | 1 |
| Phalanx | 25.2 | 0 | 1 |
| Japan Advertising Agencies Association | 25.2 | 0 | 1 |
| Asahi Advertising Agency | 25.2 | 0 | 1 |
| suzuki advertising | 25.2 | 0 | 1 |
| Anderson & Lembke | 25.2 | 0 | 1 |
| Face2face | 25.2 | 0 | 1 |
| Wieden+Kennedy | 25.2 | 0 | 1 |
| Nørgård Mikkelsen | 25.2 | 0 | 1 |
| OMD | 25.2 | 0 | 1 |
| Republica | 25.2 | 0 | 1 |
| Defense Media Agency | 25.2 | 0 | 1 |
| The „paid, owned, earned media” model | 25.2 | 0 | 1 |
| Category:Advertising agencies of the Netherlands | 25.2 | 0 | 1 |
| IdeaPlane | 25.2 | 0 | 1 |
| Category:Advertising agencies based in New York City | 25.2 | 0 | 1 |
| International Journal of Pharmaceutical and Healthcare Marketing | 25.2 | 0 | 1 |
| George Stanley Gordon | 25.2 | 0 | 1 |
| Harold Mitchell | 25.2 | 0 | 1 |
| Africa | 25.2 | 0 | 1 |
| GBH | 25.2 | 0 | 1 |
| Innocean Worldwide | 25.2 | 0 | 1 |
| Admerasia | 25.2 | 0 | 1 |
| 72andSunny | 25.2 | 0 | 1 |
| Search Engine Advertising | 25.2 | 0 | 1 |
| Category:Advertising agencies of Indonesia | 25.2 | 0 | 1 |
| Red Brick Road | 25.2 | 0 | 1 |
| BETC | 25.2 | 0 | 1 |
| la comunidad | 25.2 | 0 | 1 |
| Mason & Associates | 25.2 | 0 | 1 |
| Matari Advertising | 25.2 | 0 | 1 |
| Lopez Negrete Communications | 25.2 | 0 | 1 |
| McGarrah Jessee | 25.2 | 0 | 1 |
| dairy and poultry supply management in Canada | 25.2 | 0 | 1 |
| Spark Foundry | 25.2 | 0 | 1 |
| Tom, Dick & Harry Creative Co. | 25.2 | 0 | 1 |
| Nail Communications | 25.2 | 0 | 1 |
| WORK Labs | 25.2 | 0 | 1 |
| PeakBiety Branding + Advertising | 25.2 | 0 | 1 |
| Rothco | 25.2 | 0 | 1 |
| Solve | 25.2 | 0 | 1 |
| USFI | 25.2 | 0 | 1 |
| Trans-Canada Advertising Agency Network | 25.2 | 0 | 1 |
| Porterhouse Media | 25.2 | 0 | 1 |
| Anthrax scare a hoax for two New Zealand media agencies | 25.2 | 0 | 1 |
| Doe-Anderson Inc. | 25.2 | 0 | 1 |
| Primacy | 25.2 | 0 | 1 |
| Erva-Latvala | 25.2 | 0 | 1 |
| Turkama & Kumppanit | 25.2 | 0 | 1 |
| Blumenstock Bros Advertising Agency v. Curtis Pub Company | 25.2 | 0 | 1 |
| Katie van Scherpenberg | 25.2 | 0 | 1 |
| Q19977675 | 25.2 | 0 | 1 |
| Valentin&Byhr Reklambyrå | 25.2 | 0 | 1 |
| YG Plus | 25.2 | 0 | 1 |
| Rock Candy Media | 25.2 | 0 | 1 |
| Win rate | 25.2 | 0 | 1 |
| BrandMoxie | 25.2 | 0 | 1 |
| SEK | 25.2 | 0 | 1 |
| Team One | 25.2 | 0 | 1 |
| Starcom Mediavest Group | 25.2 | 0 | 1 |
| The Creative Counsel | 25.2 | 0 | 1 |
| Certificate of public convenience and necessity | 25.2 | 0 | 1 |
| Havas London | 25.2 | 0 | 1 |
| Mistress | 25.2 | 0 | 1 |
| Category:Advertising agencies of the United Arab Emirates | 25.2 | 0 | 1 |
| Category:Advertising agencies of Italy | 25.2 | 0 | 1 |
| Category:Outdoor advertising agencies | 25.2 | 0 | 1 |
| Category:Mass media agency | 25.2 | 0 | 1 |
| Domestic secondary lead industry: production and regulatory compliance costs | 25.2 | 0 | 1 |
| Protocol for a systematic review on the effect of demand generation interventions on uptake and use of modern contraceptives in LMIC | 25.2 | 0 | 1 |
| Catena Media | 25.2 | 0 | 1 |
| Profiles in healthcare marketing | 25.2 | 0 | 1 |
| Effectiveness of demand generation interventions on use of modern contraceptives in low- and middle-income countries | 25.2 | 0 | 1 |
| Zambezi advertising agency | 25.2 | 0 | 1 |
| Online Compliance Consortium | 25.2 | 0 | 1 |
| Workplace violence and hospital security programs: regulatory compliance, program benchmarks, innovative strategies | 25.2 | 0 | 1 |
| Caulfield & Tensing | 25.2 | 0 | 1 |
| Regulatory compliance for point-of-care testing: 2009 United States perspective | 25.2 | 0 | 1 |
| PriMedia Inc | 25.2 | 0 | 1 |
| Balance in Criminal Law Review Group | 25.2 | 0 | 1 |
| Computer-based data collection boosts productivity, regulatory compliance. | 25.2 | 0 | 1 |
| Maintaining high-volume, low-pressure surface-coating regulatory compliance using the U.s. Environmental Protection Agency's data quality objectives process | 25.2 | 0 | 1 |
| Category:Advertising agencies of China | 25.2 | 0 | 1 |
| Data privacy considerations in Intensive Care Grids | 25.2 | 0 | 1 |
| McCANN Tel Aviv | 25.2 | 0 | 1 |
| A review of the UK methodology used for monitoring cigarette smoke yields, aspects of analytical data variability and their impact on current and future regulatory compliance | 25.2 | 0 | 1 |
| Legal review: AIDS patient records--legal issues of access and disclosure | 25.2 | 0 | 1 |
| Legal review: informed consent--a shift from paternalism to self-determination? | 25.2 | 0 | 1 |
| Legal review: access to adoption records--recent developments in case and statutory law. | 25.2 | 0 | 1 |
| Legal review: The Patient Self-Determination Act--"Miranda" rights in health care. | 25.2 | 0 | 1 |
| Legal review: coping with celebrity patients | 25.2 | 0 | 1 |
| Legal review: the medical records implications of state and federal anti-dumping provisions | 25.2 | 0 | 1 |
| Legal review: free coding instruction for physicians' office staff--Medicare fraud? | 25.2 | 0 | 1 |
| Legal review: auto-authentication of medical records raises verification concerns | 25.2 | 0 | 1 |
| Legal review: a case study from California--the sharing of peer review information between hospitals and nonhospital providers. | 25.2 | 0 | 1 |
| Legal review: protecting the confidentiality and integrity of patient records | 25.2 | 0 | 1 |
| Legal review: the dilemma of access versus confidentiality. | 25.2 | 0 | 1 |
| Healthcare marketing: looking ahead to the 1990s | 25.2 | 0 | 1 |
| Legal review: confidentiality of drug and alcohol abuse patient records. Part 1. | 25.2 | 0 | 1 |
| Legal review: substance abuse record confidentiality and child abuse reporting requirements. Part 2. | 25.2 | 0 | 1 |
| Compliance with vessel speed restrictions to protect North Atlantic right whales | 25.2 | 0 | 1 |
| Price and distribution policies in healthcare marketing in Romania | 25.2 | 0 | 1 |
| A medico-legal review of some current UK guidelines in orthodontics: a personal view | 25.2 | 0 | 1 |
| A day in the life of an advertising man: review of internal documents from the UK tobacco industry's principal advertising agencies | 25.2 | 0 | 1 |
| The Year 2000 legal review. | 25.2 | 0 | 1 |
| Pathology archive: evaluation of integrity, regulatory compliance, and construction of searchable database from print reports. | 25.2 | 0 | 1 |
| A medico-legal review of cases involving quadriplegia following cervical spine surgery: Is there an argument for a no-fault compensation system? | 25.2 | 0 | 1 |
| Architecture of a consent management suite and integration into IHE-based regional health information networks | 25.2 | 0 | 1 |
| Individual and collective responsibility to enhance regulatory compliance of the Three Rs | 25.2 | 0 | 1 |
| Laser-thinning of MoS₂: on demand generation of a single-layer semiconductor | 25.2 | 0 | 1 |
| Improving access to emergency contraception pills through strengthening service delivery and demand generation: a systematic review of current evidence in low and middle-income countries | 25.2 | 0 | 1 |
| Probiotics and prebiotics: health claim substantiation | 25.2 | 0 | 1 |
| Work plan outlines areas for compliance review | 25.2 | 0 | 1 |
| "GWM looking for sex-SERIOUS ONLY": The interplay of sexual ad placement frequency and success on the sexual health of "men seeking men" on Craigslist | 25.2 | 0 | 1 |
| HIPAA: update on rule revisions and compliance requirements. | 25.2 | 0 | 1 |
| Demand generation and social mobilisation for integrated community case management (iCCM) and child health: Lessons learned from successful programmes in Niger and Mozambique | 25.2 | 0 | 1 |
| Demand generation activities and modern contraceptive use in urban areas of four countries: a longitudinal evaluation | 25.2 | 0 | 1 |
| Functional foods and food supplements for athletes: from myths to benefit claims substantiation through the study of selected biomarkers | 25.2 | 0 | 1 |
| OIG 2003 work plan outlines areas for compliance review | 25.2 | 0 | 1 |
| Telerehabilitation Store and Forward Applications: A Review of Applications and Privacy Considerations in Physical and Occupational Therapy Practice | 25.2 | 0 | 1 |
| Development and implementation of a dedicated postoperative evaluation service to improve compliance of postoperative visits | 25.2 | 0 | 1 |
| The concept of marketing in the public-private partnership in the medical system in Romania | 25.2 | 0 | 1 |
| A New Approach for On-Demand Generation of Various Oxygen Tensions for In Vitro Hypoxia Models | 25.2 | 0 | 1 |
| OIG 2005 work plan outlines areas for compliance review. | 25.2 | 0 | 1 |
| Security practices and regulatory compliance in the healthcare industry | 25.2 | 0 | 1 |
| Use of botanicals in food supplements. Regulatory scope, scientific risk assessment and claim substantiation. 2005. | 25.2 | 0 | 1 |
| Determination of total trans fats and oils by infrared spectroscopy for regulatory compliance | 25.2 | 0 | 1 |
| Q36865556 | 25.2 | 0 | 1 |
| Regulatory compliance in solid-organ transplantation: what you don't know can hurt your program | 25.2 | 0 | 1 |
| On-Demand Generation of a Formaldehyde-in-Air Standard | 25.2 | 0 | 1 |
| Regulatory compliance in the dental office | 25.2 | 0 | 1 |
| Healthcare marketing on the web: moving forward toward more interactive practices | 25.2 | 0 | 1 |
| Trans fat labeling and levels in U.S. foods: assessment of gas chromatographic and infrared spectroscopic techniques for regulatory compliance | 25.2 | 0 | 1 |
| TBWA\HAKUHODO | 25.2 | 0 | 1 |
| A medical-legal review regarding the standard of care for epidural injections, with particular reference to a closed case | 25.2 | 0 | 1 |
| Infection control and hazards management. Economics of regulatory compliance | 25.2 | 0 | 1 |
| Institutional not-for-cause compliance review programs | 25.2 | 0 | 1 |
| Mobile Health Application Regulations and Compliance Review | 25.2 | 0 | 1 |
| A Clinical and Medico-Legal Review of Tubal Ligation in Canada | 25.2 | 0 | 1 |
| Consensus-Oriented Group Peer Review: A New Process to Review Radiologist Work Output | 25.2 | 0 | 1 |
| Q38201864 | 25.2 | 0 | 1 |
| A legal review of autism, a syndrome rapidly gaining wide attention within our society | 25.2 | 0 | 1 |
| Emergency medical services naloxone access: a national systematic legal review | 25.2 | 0 | 1 |
| Sadie M. Callan | 25.2 | 0 | 1 |
| A Medical-Legal Review of Power Morcellation in the Face of the Recent FDA Warning and Litigation | 25.2 | 0 | 1 |
| Standard operating procedure for audio visual recording of informed consent: An initiative to facilitate regulatory compliance | 25.2 | 0 | 1 |
| A comparison of the results of regulatory compliance inspections in 1999 by the states of Texas, Maine, and Washington | 25.2 | 0 | 1 |
| Radiation safety program outcomes as indicated by regulatory compliance activities from 1988 to 1997 in Texas | 25.2 | 0 | 1 |
| Cause-effect relationships in nutritional intervention studies for health claims substantiation: guidance for trial design. | 25.2 | 0 | 1 |
| Legal Review for Testing of Drugs in Hair | 25.2 | 0 | 1 |
| Disinfection byproduct regulatory compliance surrogates and bromide-associated risk | 25.2 | 0 | 1 |
| Implementation of Good Laboratory Practices (GLP) in basic scientific research: Translating the concept beyond regulatory compliance | 25.2 | 0 | 1 |
| Regulatory Compliance in Mammography | 25.2 | 0 | 1 |
| Stability Testing of Herbal Drugs: Challenges, Regulatory Compliance and Perspectives | 25.2 | 0 | 1 |
| Photopatternable and photoactive hydrogel for on-demand generation of hydrogen peroxide in cell culture. | 25.2 | 0 | 1 |
| Chemical quality and regulatory compliance of drinking water in Iceland | 25.2 | 0 | 1 |
| Consumer attitudes toward healthcare marketing practices: a comparison of hospitals vs. physicians | 25.2 | 0 | 1 |
| The dentist and patient--a legal review | 25.2 | 0 | 1 |
| The effect of earned and paid media strategies in high visibility enforcement campaigns | 25.2 | 0 | 1 |
| Regional Review Boards of Ontario: a medico-legal review | 25.2 | 0 | 1 |
| The future of healthcare marketing: who's in charge? | 25.2 | 0 | 1 |
| Occupational safety and regulatory compliance in US commercial fishing | 25.2 | 0 | 1 |
| Legal review of the Brodrick Committee report | 25.2 | 0 | 1 |
| A case study for a psychographic-behavioral segmentation approach for targeted demand generation in voluntary medical male circumcision | 25.2 | 0 | 1 |
| Legal review of contracts can save hospitals time and money. | 25.2 | 0 | 1 |
| Key tasks in healthcare marketing: assessing importance and current level of knowledge. | 25.2 | 0 | 1 |
| Watershed monitoring and modelling and USA regulatory compliance. | 25.2 | 0 | 1 |
| EPA's GLP compliance review of chemistry laboratories. | 25.2 | 0 | 1 |
| Microfluidic platform for on-demand generation of spatially indexed combinatorial droplets | 25.2 | 0 | 1 |
| The Unites States Department of Agriculture Regulation of Veterinary Biological Products. The use of prelicensing evaluation and postlicensing monitoring to achieve regulatory compliance | 25.2 | 0 | 1 |
| The baby boomers turn 40. Implications for healthcare marketing. | 25.2 | 0 | 1 |
| Healthcare marketing. Looking into the 1990's | 25.2 | 0 | 1 |
| Prenatal HIV Screening in Pregnant Women: A Medical-Legal Review | 25.2 | 0 | 1 |
| An audit of implant practice websites: content and regulatory compliance | 25.2 | 0 | 1 |
| Media buyers must select stations carefully and be savvy negotiators when purchasing radio spots | 25.2 | 0 | 1 |
| Quality of drug stores: Storage practices & Regulatory compliance in Karachi, Pakistan | 25.2 | 0 | 1 |
| A novel approach to achieving modular retrovirus clearance for a parvovirus filter | 25.2 | 0 | 1 |
| An HIV testing conundrum: balancing the health and privacy considerations of multiple stakeholders | 25.2 | 0 | 1 |
| Quality of pharmacy services and regulatory compliance | 25.2 | 0 | 1 |
| Sensation seekers as a healthcare marketing metasegment | 25.2 | 0 | 1 |
| Statutory presumption, more on statutes of limitations, and the concept of "closely regulated industries". | 25.2 | 0 | 1 |
| The analysis of flue gas treatment residues using non-destructive X-ray fluorescence as a regulatory compliance test. | 25.2 | 0 | 1 |
| Variability control: key to regulatory compliance and sustainability goals | 25.2 | 0 | 1 |
| The impact of regulatory compliance behavior on hazardous waste generation in European private healthcare facilities. | 25.2 | 0 | 1 |
| Package leaflets of the most consumed medicines in Portugal: safety and regulatory compliance issues. A descriptive study. | 25.2 | 0 | 1 |
| POCT regulatory compliance: what is it and how does it impact you? | 25.2 | 0 | 1 |
| A report from CPhI Worldwide 2013, Fifth Annual Pre-Connect Conference (October 22-24, 2013 - Frankfurt, Germany) | 25.2 | 0 | 1 |
| Microbiological Water Methods: Quality Control Measures for Federal Clean Water Act and Safe Drinking Water Act Regulatory Compliance | 25.2 | 0 | 1 |
| Wheeling Walks: a community campaign using paid media to encourage walking among sedentary older adults | 25.2 | 0 | 1 |
| Lead (Pb) quantification in potable water samples: implications for regulatory compliance and assessment of human exposure. | 25.2 | 0 | 1 |
| Unprecedented nationwide paid media campaign on impaired driving yields strong results: "You Drink and Drive. You Lose." campaign scores with target market | 25.2 | 0 | 1 |
| The view and responsibility of the advertising agency toward advertising claims | 25.2 | 0 | 1 |
| Privacy considerations in the context of an Australian observational database | 25.2 | 0 | 1 |
| Regulatory compliance and the zebrafish | 25.2 | 0 | 1 |
| OSHA's permissible exposure limits: regulatory compliance versus health risk | 25.2 | 0 | 1 |
| On-demand generation and mixing of liquid-in-gas slugs with digitally-programmable composition and size | 25.2 | 0 | 1 |
| Regulatory Compliance Tips for New Dentists | 25.2 | 0 | 1 |
| Spin cycles. Healthcare marketing-communications efforts have taken on increasing strategic importance. | 25.2 | 0 | 1 |
| RFC 8065: Privacy Considerations for IPv6 Adaptation-Layer Mechanisms | 25.2 | 0 | 1 |
| Should preemption apply in a pharmaceutical context? An analysis of the preemption debate and what regulatory compliance statutes contribute to the discussion. | 25.2 | 0 | 1 |
| RFC 6973: Privacy Considerations for Internet Protocols | 25.2 | 0 | 1 |
| Predicting Regulatory Compliance in Beer Advertising on Facebook | 25.2 | 0 | 1 |
| RFC 7824: Privacy Considerations for DHCPv6 | 25.2 | 0 | 1 |
| RFC 7819: Privacy Considerations for DHCP | 25.2 | 0 | 1 |
| RFC 7626: DNS Privacy Considerations | 25.2 | 0 | 1 |
| RFC 7721: Security and Privacy Considerations for IPv6 Address Generation Mechanisms | 25.2 | 0 | 1 |
| RFC 5274: Certificate Management Messages over CMS (CMC): Compliance Requirements | 25.2 | 0 | 1 |
| Adoption of regulatory compliance programmes across United States healthcare organizations: a view of institutional disobedience | 25.2 | 0 | 1 |
| Organizational Performance and Regulatory Compliance as Measured by Clinical Pertinence Indicators Before and After Implementation of Anesthesia Information Management System (AIMS) | 25.2 | 0 | 1 |
| Telling their stories. Healthcare marketing, advertising emphasize the personal approach as providers find new ways to connect with patients | 25.2 | 0 | 1 |
| Important privacy considerations with electronic health record documentation. | 25.2 | 0 | 1 |
| The use of mobile computed tomography in intensive care: regulatory compliance and radiation protection | 25.2 | 0 | 1 |
| Genetics and Insurance in Australia: Concerns around a Self-Regulated Industry | 25.2 | 0 | 1 |
| High-performance marketing: an interview with Nike's Phil Knight. Interview by Geraldine E. Willigan | 25.2 | 0 | 1 |
| Ads add up. Healthcare advertising can make dollars and sense. Interview by Joyce Jensen | 25.2 | 0 | 1 |
| Which way is up? How healthcare marketing stays afloat in tough economic times. Interview by Richard K. Thomas | 25.2 | 0 | 1 |
| How far have we come? A look back at 25 years of healthcare marketing. Interview by Richard K. Thomas. | 25.2 | 0 | 1 |
| Conducting research on issues regarding human subjects research regulatory compliance: a responsibility of all clinical researchers | 25.2 | 0 | 1 |
| Consumer reaction to healthcare advertising. | 25.2 | 0 | 1 |
| Clinical RNs lead quality improvement | 25.2 | 0 | 1 |
| Quality Control for Federal Clean Water Act and Safe Drinking Water Act Regulatory Compliance | 25.2 | 0 | 1 |
| BSE regulatory compliance for plastic components | 25.2 | 0 | 1 |
| The use of total quality principles to achieve regulatory compliance in research laboratories. | 25.2 | 0 | 1 |
| Health claims substantiation for probiotic and prebiotic products | 25.2 | 0 | 1 |
| Re: Perioperative ulnar neuropathies; a medical legal review. John D. Stewart, Stephen H. Shantz. Can J Neurol Sci 2003; 30: 15-19. | 25.2 | 0 | 1 |
| The next generation. New models for earned, owned and paid media | 25.2 | 0 | 1 |
| On-demand generation of monodisperse femtolitre droplets by shape-induced shear. | 25.2 | 0 | 1 |
| An examination into audience targeting and the use of storytelling or statistical evidence on breast cancer websites | 25.2 | 0 | 1 |
| Calibration and maintenance: centralized system increases regulatory compliance | 25.2 | 0 | 1 |
| RBK Advertising | 25.2 | 0 | 1 |
| Regulatory compliance issues in behavioral health | 25.2 | 0 | 1 |
| Teaching healthcare marketing via community research: the LifeFlight project. | 25.2 | 0 | 1 |
| A quality-adjusted cost function in a regulated industry: the case of Dutch nursing homes | 25.2 | 0 | 1 |
| Administrators should tell advertising agency risks, rewards of working with a hospital. | 25.2 | 0 | 1 |
| On-Demand Generation of Neutral and Negatively Charged Silicon-Vacancy Centers in Diamond. | 25.2 | 0 | 1 |
| On-demand generation of an efficient catalyst for pyridine formation from unactivated nitriles and alpha,omega-diynes using CoCl2-6H2O, dppe, and Zn. | 25.2 | 0 | 1 |
| National Systematic Legal Review of State Policies on Emergency Medical Services Licensure Levels' Authority to Administer Opioid Antagonists | 25.2 | 0 | 1 |
| FDA regulatory compliance reconsidered. | 25.2 | 0 | 1 |
| Establishing pan-European clinical trials: regulatory compliance and other practical considerations | 25.2 | 0 | 1 |
| International Regulatory Compliance. | 25.2 | 0 | 1 |
| A single-laboratory validated method for the generation of DNA barcodes for the identification of fish for regulatory compliance | 25.2 | 0 | 1 |
| Growing public scrutiny of FDA clinical trials: ethical and regulatory compliance to avoid "uninformed consent" and financial conflicts of interest | 25.2 | 0 | 1 |
| A new approach to healthcare marketing. | 25.2 | 0 | 1 |
| Deterring inefficient pharmaceutical litigation: an economic rationale for the FDA regulatory compliance defense. | 25.2 | 0 | 1 |
| KesselsKramer | 25.2 | 0 | 1 |
| Quantitative whole-body autoradiography in the pharmaceutical industry. Survey results on study design, methods, and regulatory compliance | 25.2 | 0 | 1 |
| The role of healthcare marketing: in the aftermath of the anti-referral movement | 25.2 | 0 | 1 |
| Healthcare Professionals and the Ethics of Healthcare Marketing | 25.2 | 0 | 1 |
| The History of an Advertising Agency: N. W. Ayer & Sons at Work, 1869-1949, Revised Edition | 25.2 | 0 | 1 |
| RFC 8386: Privacy Considerations for Protocols Relying on IP Broadcast or Multicast | 25.2 | 0 | 1 |
| Surgery and blood transfusion in Jehovah's witnesses: a medical-legal review | 25.2 | 0 | 1 |
| DiMassimo Goldstein | 25.2 | 0 | 1 |
| Johannes Leonardo | 25.2 | 0 | 1 |
| Siltanen & Partners | 25.2 | 0 | 1 |
| Establishing Regulatory Compliance for Software Requirements | 25.2 | 0 | 1 |
| Green Clubs and Voluntary Governance: ISO 14001 and Firms' Regulatory Compliance | 25.2 | 0 | 1 |
| Haasenstein & Vogler | 25.2 | 0 | 1 |
| Fama | 25.2 | 0 | 1 |
| Citation Analysis: An Approach for Facilitating the Understanding and the Analysis of Regulatory Compliance Documents | 25.2 | 0 | 1 |
| A legal cross-references taxonomy for reasoning about compliance requirements | 25.2 | 0 | 1 |
| Trajanic building projects on base-metal denominations and audience targeting | 25.2 | 0 | 1 |
| Consent Redux. An Illinois medical center moves from paper to automated informed consent to meet regulatory compliance, reduce errors and facilitate communication | 25.2 | 0 | 1 |
| BYOD: Security and Privacy Considerations | 25.2 | 0 | 1 |
| Microfluidic and optical systems for the on-demand generation and manipulation of single femtoliter-volume aqueous droplets | 25.2 | 0 | 1 |
| Diagnostic Information for Compliance Checking of Temporal Compliance Requirements | 25.2 | 0 | 1 |
| The State of Digital Interventions for Demand Generation in Low- and Middle-Income Countries: Considerations, Emerging Approaches, and Research Gaps | 25.2 | 0 | 1 |
| Celebrity endorsement, brand credibility and brand equity | 25.2 | 0 | 1 |
| Do Membership Benefits Buy Regulatory Compliance? | 25.2 | 0 | 1 |
| Economic contradictions coming home to roost? Does the U.S. economy face a long-term aggregate demand generation problem? | 25.2 | 0 | 1 |
| Procedural justice and regulatory compliance | 25.2 | 0 | 1 |
| CRIMINOLOGICAL THEORIES AND REGULATORY COMPLIANCE* | 25.2 | 0 | 1 |
| Semantic Business Process Regulatory Compliance Checking Using LegalRuleML | 25.2 | 0 | 1 |
| Interlocking directorships and firm performance in highly regulated sectors: the moderating impact of board diversity | 25.2 | 0 | 1 |
| insurance marketing | 25.2 | 0 | 1 |
| Governance of big data collaborations: How to balance regulatory compliance and disruptive innovation | 25.2 | 0 | 1 |
| A special accounting treatment for regulated industries? The case of the port wine industry | 25.2 | 0 | 1 |
| Mytaste Group | 25.2 | 0 | 1 |
| The role of brand credibility in predicting consumers' behavioural intentions in luxury restaurants | 25.2 | 0 | 1 |
| Business Process Regulatory Compliance is Hard | 25.2 | 0 | 1 |
| Normative requirements for regulatory compliance: An abstract formal framework | 25.2 | 0 | 1 |
| Managing Regulatory Compliance in Business Processes | 25.2 | 0 | 1 |
| Managing Regulatory Compliance in Business Processes | 25.2 | 0 | 1 |
| Detecting Regulatory Compliance for Business Process Models through Semantic Annotations | 25.2 | 0 | 1 |
| Foreign capital, forest change and regulatory compliance in Congo Basin forests | 25.2 | 0 | 1 |
| Explaining the Origins of the Advertising Agency | 25.2 | 0 | 1 |
| From T-Square to T-Plan: The London Office of the J. Walter Thompson Advertising Agency 1919–70 | 25.2 | 0 | 1 |
| A Review of “Advertising Media Planning: A Brand Management Approach” | 25.2 | 0 | 1 |
| Chapter 7. Advertising and Media Planning Sources | 25.2 | 0 | 1 |
| American Advertising Agencies in Europe: J. Walter Thompson's Belgian Business in the Inter-War Years | 25.2 | 0 | 1 |
| While A Burden for Corporate it, Regulatory Compliance Creates Significant Opportunities for it Vendors | 25.2 | 0 | 1 |
| AAAA (The American Association of Advertising Agencies) | 25.2 | 0 | 1 |
| A cross-industry analysis of the spillover effect in paid search advertising | 25.2 | 0 | 1 |
| Practical applications of healthcare marketing ethics | 25.2 | 0 | 1 |
| MAGIC: once upon a time in consent management-a FHIR tale | 25.2 | 0 | 1 |
| Safety and Privacy Considerations for Mobile Application Design in Digital Healthcare | 25.2 | 0 | 1 |
| The effects of brand credibility on customer loyalty | 25.2 | 0 | 1 |
| Brand Credibility, Brand Consideration, and Choice | 25.2 | 0 | 1 |
| The impact of brand credibility on consumer price sensitivity | 25.2 | 0 | 1 |
| The timing of tariff structure changes in regulated industries: evidence from England and Wales | 25.2 | 0 | 1 |
| ASTM E1958 | 25.2 | 0 | 1 |
| ASTM E2107 | 25.2 | 0 | 1 |
| Beefing Up End User Development: Legal Protection and Regulatory Compliance | 25.2 | 0 | 1 |
| Simple, robust, and on-demand generation of single and correlated photons | 25.2 | 0 | 1 |
| On-demand generation of background-free single photons from a solid-state source | 25.2 | 0 | 1 |
| Title X Family Planning: Proposed Rule on Statutory Compliance Requirements | 25.2 | 0 | 1 |
| Regulatory compliance as fulfilment of corporate social responsibility: an interpretative textual analysis on sustainability reports of two Chinese listed agribusinesses | 25.2 | 0 | 1 |
| Semantic hierarchies for extracting, modeling, and connecting compliance requirements in information security control standards | 25.2 | 0 | 1 |
| Anhui Establishes Legal Review For Internal Government Directives | 25.2 | 0 | 1 |
| Global Scan: The Globalization of Advertising Agencies, Concepts, and Campaigns | 25.2 | 0 | 1 |
| On-Demand Generation of Entangled Multiphoton States | 25.2 | 0 | 1 |
| Brand safety: the effects of controversial video content on pre-roll advertising | 25.2 | 0 | 1 |
| Q60982536 | 25.2 | 0 | 1 |
| Crossmedia | 25.2 | 0 | 1 |
| On-demand generation of entanglement of atomic qubits via optical interferometry | 25.2 | 0 | 1 |
| Pharmaceutical advertising practitioners' approach to trust and emotion | 25.2 | 0 | 1 |
| Extreme Pulses in Optically Injected Semiconductor Lasers: Precursors and On-demand Generation | 25.2 | 0 | 1 |
| Managing legal interpretation in regulatory compliance | 25.2 | 0 | 1 |
| GaiusT: supporting the extraction of rights and obligations for regulatory compliance | 25.2 | 0 | 1 |
| Political Price Cycles in Regulated Industries: Theory and Evidence | 25.2 | 0 | 1 |
| St. Luke's | 25.2 | 0 | 1 |
| François Cariot | 25.2 | 0 | 1 |
| The lab management practices of "Research Exemplars" that foster research rigor and regulatory compliance: A qualitative study of successful principal investigators | 25.2 | 0 | 1 |
| Privacy-Preserving Record Grouping and Consent Management Based on a Public-Private Key Signature Scheme: Theoretical Analysis and Feasibility Study | 25.2 | 0 | 1 |
| Compliance Review Information System File (NAID 636508) | 25.2 | 0 | 1 |
| Regulatory Compliance Records (NAID 122426308) | 25.2 | 0 | 1 |
| Original Complaint and Compliance Review Case Files (NAID 621976) | 25.2 | 0 | 1 |
| Posters Advertising Agency Programs (NAID 542433) | 25.2 | 0 | 1 |
| Compliance Review Files (NAID 27022647) | 25.2 | 0 | 1 |
| Evaluating Demand Generation (Stylish Man , Stylish Living) for HIV Prevention/Family Planning Services, Rakai, Uganda | 25.2 | 0 | 1 |
| Correspondence Received From Advertising Agencies (NAID 877007) | 25.2 | 0 | 1 |
| Correspondence with Outdoor Advertising Agencies (NAID 875689) | 25.2 | 0 | 1 |
| OTS Advertising | 25.2 | 0 | 1 |
| State Advertising Agency | 25.2 | 0 | 1 |
| brand safety | 25.2 | 0 | 1 |
| Initiative | 25.2 | 0 | 1 |
| Evaluating Demand Generation for Safe Voluntary Male Circumcision (VMC) for HIV Prevention (Stylish Man), Rakai, Uganda | 25.2 | 0 | 1 |
| Category:Mass media agencies of Albania | 25.2 | 0 | 1 |
| Q65963006 | 25.2 | 0 | 1 |
| Tunatar da ni. The Immunization Reminder and Information SMS System (IRISS) | 25.2 | 0 | 1 |
| G. H. Saxon Mills | 25.2 | 0 | 1 |
| Compliance Review Files (NAID 7906892) | 25.2 | 0 | 1 |
| Interpretation Files by Legal Review (NAID 7694747) | 25.2 | 0 | 1 |
| Title VI Compliance Review Files (NAID 7564755) | 25.2 | 0 | 1 |
| Medical legal review | 25.2 | 0 | 1 |
| Regulatory compliance of business processes | 25.2 | 0 | 1 |
| Healthcare marketing and the nurse manager | 25.2 | 0 | 1 |
| Making business sense of regulatory compliance | 25.2 | 0 | 1 |
| Individual privacy considerations for computerized health information systems | 25.2 | 0 | 1 |
| Hospital groups lead quality studies in 1989 | 25.2 | 0 | 1 |
| Medical insurance marketing | 25.2 | 0 | 1 |
| Recruitment--5. The role of an advertising agency in the recruitment exercise | 25.2 | 0 | 1 |
| New TV spot highlights '93 media plan | 25.2 | 0 | 1 |
| ISO 9000. Policy implications for FDA. Taking the pulse of increasing global use of the ISO series of uniform quality standards by FDA regulated industries | 25.2 | 0 | 1 |
| What to look for during a compliance review: 10 common mistakes made by SNFs | 25.2 | 0 | 1 |
| Healthcare marketing strategies | 25.2 | 0 | 1 |
| Regulatory compliance in the ambulatory surgery setting: a process improvement approach | 25.2 | 0 | 1 |
| Claim substantiation and efficiency of hydrating body lotions and protective creams | 25.2 | 0 | 1 |
| What medical advertising agencies expect of medical journalists | 25.2 | 0 | 1 |
| Regulatory compliance for point-of-care testing. A perspective from the United States (Circa 2000) | 25.2 | 0 | 1 |
| Risk and the economics of regulatory compliance | 25.2 | 0 | 1 |
| Keynote paper: reassessing regulatory compliance | 25.2 | 0 | 1 |
| Rewarding regulatory compliance: the pursuit of symmetry in products liability | 25.2 | 0 | 1 |
| Regulatory compliance preclusion of tort liability: limiting the dual-track system | 25.2 | 0 | 1 |
| Studio Palm | 25.2 | 0 | 1 |
| Assessing the consequences of corporate discretion on regulatory compliance: the case of motor vehicle safety in Canada | 25.2 | 0 | 1 |
| Physician bonding: a new strategy in healthcare marketing | 25.2 | 0 | 1 |
| Specialized forms promote regulatory compliance | 25.2 | 0 | 1 |
| FTC getting tough on false healthcare advertising | 25.2 | 0 | 1 |
| Claim substantiation in the health care industry | 25.2 | 0 | 1 |
| Pharmacist–Patient Privilege, Confidentiality, and Legally-Mandated Counseling: A Legal Review | 25.2 | 0 | 1 |
| Back up healthcare marketing with infection-control basics | 25.2 | 0 | 1 |
| Changing consumer perceptions in healthcare marketing | 25.2 | 0 | 1 |
| One-to-one approach catches on. Proven in other industries, now popular in healthcare marketing | 25.2 | 0 | 1 |
| Combating billing problems. Regulatory compliance programs offer many benefits | 25.2 | 0 | 1 |
| Thermometers used for regulatory compliance | 25.2 | 0 | 1 |
| Healthcare marketing: maximizing your competitive position | 25.2 | 0 | 1 |
| Coordinating a strong media plan | 25.2 | 0 | 1 |
| Tritium doses from chronic atmospheric releases: a new approach proposed for regulatory compliance | 25.2 | 0 | 1 |
| Selecting an advertising agency: look before you leap | 25.2 | 0 | 1 |
| Healthcare marketing and the regional model | 25.2 | 0 | 1 |
| Selecting and working with an advertising agency | 25.2 | 0 | 1 |
| Healthcare advertising: what you can and cannot say | 25.2 | 0 | 1 |
| Healthcare marketing. A model for HMO services to the elderly | 25.2 | 0 | 1 |
| End-of-life care in the nursing home--is a good death compatible with regulatory compliance? | 25.2 | 0 | 1 |
| Physicians as business partners in healthcare marketing | 25.2 | 0 | 1 |
| The healthcare account executive--a sales approach to healthcare marketing | 25.2 | 0 | 1 |
| Computerization and healthcare marketing | 25.2 | 0 | 1 |
| The hospital marketer and the advertising agency: who should do what--and to whom | 25.2 | 0 | 1 |
| Syndicated healthcare advertising increasing despite some doubts about its effectiveness | 25.2 | 0 | 1 |
| Healthcare marketing--using HIS resources | 25.2 | 0 | 1 |
| The role of the hospital trustee in healthcare marketing | 25.2 | 0 | 1 |
| Selecting an advertising agency--a nail-biting crapshoot | 25.2 | 0 | 1 |
| Healthcare advertising: overstating the case? | 25.2 | 0 | 1 |
| Legal review highlights RN/LPN compact flaws | 25.2 | 0 | 1 |
| The healthcare marketing professional. Mature and flourishing at the top | 25.2 | 0 | 1 |
| Strategic media planning: furthering the impact of health care advertising | 25.2 | 0 | 1 |
| The next generation of healthcare advertising: marketing to women | 25.2 | 0 | 1 |
| Healthcare advertising: a new focus, strategically speaking | 25.2 | 0 | 1 |
| In healthcare marketing, all households are not created equal | 25.2 | 0 | 1 |
| Confidentiality: insurers balance needs against privacy considerations | 25.2 | 0 | 1 |
| New directions in nursing home and home healthcare marketing | 25.2 | 0 | 1 |
| Using commercial advertising agencies in micronutrient promotion: lessons learned | 25.2 | 0 | 1 |
| L4 Group LLC | 25.2 | 0 | 1 |
| GSHMPR: taking on the new challenges of health care marketing. Georgia Society for Healthcare Marketing & Public Relations | 25.2 | 0 | 1 |
| Svensk advertis!ng : oberoende tidskrift för visualizing, merchandizing, sales promotion, copy directing, media planning, innovation, public relations, art direction, communication, realization & marknadsanpassning | 25.2 | 0 | 1 |
| Streamlining regulatory compliance through clinical systems | 25.2 | 0 | 1 |
| Boost regulatory compliance with electronic nursing documentation | 25.2 | 0 | 1 |
| Ease the pain of hazmat regulatory compliance | 25.2 | 0 | 1 |
| Magazine alcohol advertising compliance with the Australian Alcoholic Beverages Advertising Code | 25.2 | 0 | 1 |
| Air ambulance services take off. But it's 'flier beware' for the customers of a confusing, lightly regulated industry | 25.2 | 0 | 1 |
| IT tools personalize healthcare marketing and communications | 25.2 | 0 | 1 |
| Keeping up with the latest in regulatory compliance | 25.2 | 0 | 1 |
| Delegation for the International Legal Review of Weapons Projects | 25.2 | 0 | 1 |
| Surgery and transfusion in Jehovah's witness patient. Medical legal review | 25.2 | 0 | 1 |
| Rhode Island Department of Health Strategic Plan: 2004-2010. Goal 6: Quality improvement and regulatory compliance | 25.2 | 0 | 1 |
| The case for regulatory compliance of electronic medical records about human tissue intended for transplantation | 25.2 | 0 | 1 |
| The COMPLIANCE documentation aid | 25.2 | 0 | 1 |
| Healthcare marketing liability: avoiding possible pitfalls | 25.2 | 0 | 1 |
| Danger, danger: compliance documentation as a weapon | 25.2 | 0 | 1 |
| Harness technology for sustainable regulatory compliance | 25.2 | 0 | 1 |
| Healthcare marketing in the 21st century: beyond promotion to constructing experiences to achieve high performance | 25.2 | 0 | 1 |
| ADVERTISING AGENCIES | 25.2 | 0 | 1 |
| Ongoing regulatory compliance required | 25.2 | 0 | 1 |
| Consent management platform | 25.2 | 0 | 1 |
| Regulatory compliance associated with contrast media | 25.2 | 0 | 1 |
| Keeping online personal records private: security and privacy considerations for Web-based PHR systems | 25.2 | 0 | 1 |
| Keeping track of tissue in the supply chain. Monitor temperature for patient safety and regulatory compliance | 25.2 | 0 | 1 |
| How to be a healthcare marketing hero | 25.2 | 0 | 1 |
| Spring ahead. Start early in transitioning to a new advertising agency | 25.2 | 0 | 1 |
| Healthcare reform: regulations issued on early compliance requirements | 25.2 | 0 | 1 |
| Consumer access to healthcare information in Japan: relationship to healthcare advertising | 25.2 | 0 | 1 |
| Uses of 'Good Laboratory Practices' by regulated industry and agencies, and the safety of bisphenol A | 25.2 | 0 | 1 |
| Healthy, wealthy and wise. The impact of regulatory compliance on patient relationships | 25.2 | 0 | 1 |
| Online healthcare advertising needs regulation | 25.2 | 0 | 1 |
| Leadership for the triple aim. Three-pronged framework helps executives lead quality initiatives | 25.2 | 0 | 1 |
| Hazard material information management and regulatory compliance | 25.2 | 0 | 1 |
| Older adults' privacy considerations for vision based recognition methods of eldercare applications | 25.2 | 0 | 1 |
| Case management affects bottom line, quality of care, regulatory compliance | 25.2 | 0 | 1 |
| Consumer-driven healthcare marketing: using the web to get up close and personal | 25.2 | 0 | 1 |
| From media planner to media expert: The digital effect in advertising | 25.2 | 0 | 1 |
| Regulatory compliance. The regulatory framework for qualifying EHR donations | 25.2 | 0 | 1 |
| Effects of ad placement and type on consumer responses to podcast ads | 25.2 | 0 | 1 |
| Regulatory compliance: the necessary evil | 25.2 | 0 | 1 |
| Livecode Full Media Agency | 25.2 | 0 | 1 |
| Does resident or family preference always control? Resident-centered care versus regulatory compliance | 25.2 | 0 | 1 |
| GTB | 25.2 | 0 | 1 |
| Mediahub | 25.2 | 0 | 1 |
| The target in the healthcare marketing | 25.2 | 0 | 1 |
| Category:Advertising agencies of Hong Kong | 25.2 | 0 | 1 |
| Academic vascular unit collaboration with advertising agency yields higher compliance in screening for abdominal aortic aneurysm | 25.2 | 0 | 1 |
| Wavemaker | 25.2 | 0 | 1 |
| Advancing the 3Rs in regulatory toxicology - Carcinogenicity testing: Scope for harmonisation and advancing the 3Rs in regulated sectors of the European Union | 25.2 | 0 | 1 |
| Strategic public procurement regulatory compliance model with mediating effect of ethical behavior | 25.2 | 0 | 1 |
| [Consent management and workflows for cross-sectoral patient records and teleconsultations] | 25.2 | 0 | 1 |
| Managing demand generation with evidence | 25.2 | 0 | 1 |
| Improper healthcare marketing: German and Ukrainian experience in prevention | 25.2 | 0 | 1 |
| The Role of Dissolved Oxygen Levels on Human Mesenchymal Stem Cell Culture Success, Regulatory Compliance, and Therapeutic Potential | 25.2 | 0 | 1 |
| On Sharing Intentions, and Personal and Interdependent Privacy Considerations for Genetic Data: A Vignette Study | 25.2 | 0 | 1 |
| Regulatory Compliance in Online Dog Advertisements in Australia | 25.2 | 0 | 1 |
| Re: Legal Review of Vasectomy Litigation and the Variables Impacting Trial Outcomes | 25.2 | 0 | 1 |
| The Costs and Costing of Regulatory Compliance | 25.2 | 0 | 1 |
| Achieving CT Regulatory Compliance: A Comprehensive and Continuous Quality Improvement Approach | 25.2 | 0 | 1 |
| Biomimetic recyclable microgels for on-demand generation of hydrogen peroxide and antipathogenic application | 25.2 | 0 | 1 |
| Is regulatory compliance enough to ensure excellence in medicine? | 25.2 | 0 | 1 |
| On-Demand Generation of Double Emulsions Based on Interface Shearing for Controlled Ultrasound Activation | 25.2 | 0 | 1 |
| Barriers to live and deceased kidney donation by patients with chronic neurological diseases: Implications for donor selection, donation timing, logistics, and regulatory compliance | 25.2 | 0 | 1 |
| Measuring the frequency of consumer hair combing and magnitude of combing forces on individual hairs in a tress and the implications for product evaluation and claims substantiation | 25.2 | 0 | 1 |
| Validated quantitative cannabis profiling for Canadian regulatory compliance - Cannabinoids, aflatoxins, and terpenes | 25.2 | 0 | 1 |
| Conclusions from a Swiss official control of the safety assessment for food contact polyolefins through the compliance documentation of the producers | 25.2 | 0 | 1 |
| Healthcare marketing: A review of the literature based on citation analysis | 25.2 | 0 | 1 |
| A paired training curriculum and internal monitoring program for clinical research regulatory compliance in the emerging era of the single Institutional Review Board | 25.2 | 0 | 1 |
| Serialization: Benefits Beyond Regulatory Compliance | 25.2 | 0 | 1 |
| Developing a Practical Method for Validation of Computerized Systems Integrated With Smart and/or Wearable Devices for Regulatory Compliance of Clinical Trials | 25.2 | 0 | 1 |
| Tobacco regulatory compliance with STAKE Act age-of-sale signage among licensed tobacco retailers across diverse neighborhoods in Southern California | 25.2 | 0 | 1 |
| Vitriolage (vitriolism) - a medico-socio-legal review | 25.2 | 0 | 1 |
| Why the "sea of same"? A qualitative look at DTCA within the larger context of healthcare marketing | 25.2 | 0 | 1 |
| Service quality: A subliminal pathway to service differentiation and competitive advantage in private healthcare marketing in Ghana | 25.2 | 0 | 1 |
| Measuring IRB Regulatory Compliance: Development, Testing, and Use of the National Cancer Institute StART Tool | 25.2 | 0 | 1 |
| Ecotoxicological risk evaluation and regulatory compliance of endocrine disruptor phthalates in a sustainable wastewater treatment scheme | 25.2 | 0 | 1 |
| Clinical Evaluation of a Chairside Amalgam Separator to Meet Environmental Protection Agency Dental Wastewater Regulatory Compliance | 25.2 | 0 | 1 |
| Sulfuryl Fluoride Poisonings in Structural Fumigation, a Highly Regulated Industry-Potential Causes and Solutions | 25.2 | 0 | 1 |
| Legal Review of Vasectomy Litigation and the Variables Impacting Trial Outcomes | 25.2 | 0 | 1 |
| Microfluidics-Based On-Demand Generation of Nonwoven and Single Polymer Microfibers | 25.2 | 0 | 1 |
| E-Consent for Data Privacy: Consent Management for Mobile Health Technologies in Public Health Surveys and Disease Surveillance | 25.2 | 0 | 1 |
| Stress measurement using speech: Recent advancements, validation issues, and ethical and privacy considerations | 25.2 | 0 | 1 |
| Billing for living kidney donor care: Balancing cost recovery, regulatory compliance, and minimized donor burden | 25.2 | 0 | 1 |
| Laws limiting the prescribing or dispensing of opioids for acute pain in the United States: A national systematic legal review | 25.2 | 0 | 1 |
| Impact of a Monthly Compliance Review on Interventional Radiology Adverse Event Reporting | 25.2 | 0 | 1 |
| Achieving Joint Commission Regulatory Compliance: Quality Improvement Process for CT Protocol Review and Dose Alert Reduction | 25.2 | 0 | 1 |
| 2419: Clinical research management and regulatory compliance: A graduate distance learning model | 25.2 | 0 | 1 |
| THE MEDICO-LEGAL REVIEW | 25.2 | 0 | 1 |
| Taking advantage of a high-throughput flow cytometer for the implementation of an ADCC assay for regulatory compliance | 25.2 | 0 | 1 |
| Healthcare marketing elements | 25.2 | 0 | 1 |
| Approaches to Cost Recovery for Animal Research: Implications for Science, Animals, Research Competitiveness, and Regulatory Compliance | 25.2 | 0 | 1 |
| Does Hiring an Advertising Agency Cost My Dental Practice Money? | 25.2 | 0 | 1 |
| An International Legal Review of the Relationship between Brain Death and Organ Transplantation | 25.2 | 0 | 1 |
| Non-comedogenic and non-acnegenic claim substantiation | 25.2 | 0 | 1 |
| Healthcare Privacy Considerations of Body-Worn Cameras | 25.2 | 0 | 1 |
| Outsourcing your medical practice call center: how to choose a vendor to ensure regulatory compliance | 25.2 | 0 | 1 |
| On-demand generation of singlet oxygen from a smart graphene complex for the photodynamic treatment of cancer cells | 25.2 | 0 | 1 |
| Media Design | 25.2 | 0 | 1 |
| Membrane Microreactors for the On-Demand Generation, Separation and Reaction of Gases | 25.2 | 0 | 1 |
| Personal data usage and privacy considerations in the COVID-19 global pandemic | 25.2 | 0 | 1 |
| Covid-19: Woman whose father died in care home launches legal review over government's "litany of failures" | 25.2 | 0 | 1 |
| Towards a Highly Usable, Mobile Electronic Platform for Patient Recruitment and Consent Management | 25.2 | 0 | 1 |
| Madani Legal Review | 25.2 | 0 | 1 |
| Khit Thit Media | 25.2 | 0 | 1 |
| The generic Informed Consent Service gICS®: implementation and benefits of a modular consent software tool to master the challenge of electronic consent management in research | 25.2 | 0 | 1 |
| Modeling Airline Crisis Management Capability: Brand attitude, brand credibility and intention | 25.2 | 0 | 1 |
| Fran Harris-Tuchman | 25.2 | 0 | 1 |
| Harris-Tuchman Productions, inc. | 25.2 | 0 | 1 |
| Ethics and Privacy Considerations Before Deploying Sensor Technologies for Exposure Assessment in the Workplace: Results of a Structured Discussion Amongst Dutch Stakeholders | 25.2 | 0 | 1 |
| Lois Pitts Gershon | 25.2 | 0 | 1 |
| Lois Pitts Gershon Pon-GGK appointed corporate advertising agency for Intercontinental Hotels Corp | 25.2 | 0 | 1 |
| On-Demand Generation and Use in Continuous Synthesis of the Ambiphilic Nitrogen Source Chloramine | 25.2 | 0 | 1 |
| Italia/Gal | 25.2 | 0 | 1 |
| Asher-Gould | 25.2 | 0 | 1 |
| Asher/Gal | 25.2 | 0 | 1 |
| McCaffrey & McCall | 25.2 | 0 | 1 |
| VMLY&R | 25.2 | 0 | 1 |
| HDM | 25.2 | 0 | 1 |
| Sharda University School of Art Design and Media Planning | 25.2 | 0 | 1 |
| Tessab | 25.2 | 0 | 1 |
| Patient Consent Management by a Purpose-Based Consent Model for Electronic Health Record Based on Blockchain Technology | 25.2 | 0 | 1 |
| Utilizing connectivity and data management system for effective quality management and regulatory compliance in point of care testing | 25.2 | 0 | 1 |
| A Type-2 Fuzzy Logic Approach to Explainable AI for regulatory compliance, fair customer outcomes and market stability in the Global Financial Sector | 25.2 | 0 | 1 |
| Regulatory compliance of health warnings on tobacco packs in Karnataka, India | 25.2 | 0 | 1 |
| Data privacy considerations for telehealth consumers amid COVID-19 | 25.2 | 0 | 1 |
| Rubicam, Raymond (1892-1978), advertising agency executive | 25.2 | 0 | 1 |
| Nobby Clark | 25.2 | 0 | 1 |
| Amhara Mass Media Agency | 25.2 | 0 | 1 |
| 2020 Census Data Products: Data Needs and Privacy Considerations: Proceedings of a Workshop | 25.2 | 0 | 1 |
| Category:Advertising agencies of Belgium | 25.2 | 0 | 1 |
| Roy S. Durstine Inc. | 25.2 | 0 | 1 |
| Category:Advertising agencies of Switzerland | 25.2 | 0 | 1 |
| Category:Advertising agencies of Spain | 25.2 | 0 | 1 |
| Category:Advertising agencies of Ireland | 25.2 | 0 | 1 |
| Economic Factors Underlying the Unbundling of Advertising Agency Services | 25.2 | 0 | 1 |
| Consumer Heterogeneity and Paid Search Effectiveness: A Large Scale Field Experiment | 25.2 | 0 | 1 |
| Input and Technology Choices in Regulated Industries: Evidence From the Health Care Sector | 25.2 | 0 | 1 |
| Optimal Regulation of Multiply-Regulated Industries: The Case of Physician Services | 25.2 | 0 | 1 |
| Costs, Institutional Mobility Barriers, and Market Structure: Advertising Agencies as Multiproduct Firms | 25.2 | 0 | 1 |
| Scale and Scope Effects on Advertising Agency Costs | 25.2 | 0 | 1 |
| Research on Spare Demand Generation,Transfer and Analytical Algorithm | 25.2 | 0 | 1 |
| Category:Advertising agencies of Ukraine | 25.2 | 0 | 1 |
| Archer & Hound Advertising | 25.2 | 0 | 1 |
| Evaluation of suppression effect of total release aerosol containing a new candidate compound, amidoflumet, on house dust mite allergen under semi-practical conditions | 25.2 | 0 | 1 |
| FAMOUS | 25.2 | 0 | 1 |
| Prestige Networks | 25.2 | 0 | 1 |
| Las Vegas News Bureau | 25.2 | 0 | 1 |
| Desert Sea News Bureau | 25.2 | 0 | 1 |
| Healthcare Advertising Review | 25.2 | 0 | 1 |
| Information Technology Usage by Advertising Agencies in Lagos, Nigeria | 25.2 | 0 | 1 |
| RFC 9076: DNS Privacy Considerations | 25.2 | 0 | 1 |
| A strategy and framework for identifying compliance requirements under international law (with an illustration relating to international human rights norms) | 25.2 | 0 | 1 |
| Better regulatory compliance through environmental auditing: A reform whose time has passed | 25.2 | 0 | 1 |
| Effective ecosystem-based management must encourage regulatory compliance: A Gulf of California case study | 25.2 | 0 | 1 |
| Defiance and obedience: Regulatory compliance among artisanal fishers in St Helena Bay | 25.2 | 0 | 1 |
| Does the relationship between fishermen and enforcers impact regulatory compliance? | 25.2 | 0 | 1 |
| Government effectiveness, regulatory compliance and public preference for marine policy instruments. An experimental approach | 25.2 | 0 | 1 |
| Induced Policy Innovation: Environmental Compliance Requirements for Dairies in Texas and Florida | 25.2 | 0 | 1 |
| Corruption and regulatory compliance: Experimental findings from South African small-scale fisheries | 25.2 | 0 | 1 |
| Regulatory compliance and capitalist diversity in Europe | 25.2 | 0 | 1 |
| Formality and Informality in Employment Relations: The Implications for Regulatory Compliance by Smaller Firms | 25.2 | 0 | 1 |
| EXPRESS: “Get a £10 Free Bet Every Week!” – Gambling Advertising on Twitter: Volume, Content, Followers, Engagement and Regulatory Compliance | 25.2 | 0 | 1 |
| Better Regulatory Compliance through Environmental Auditing: A Reform Whose Time Has Passed | 25.2 | 0 | 1 |
| Firm Size and Regulatory Compliance Costs: The Case of Workers' Compensation Insurance | 25.2 | 0 | 1 |
| Regulatory Compliance in Opinion Poll Reporting during the 2004 Canadian Election | 25.2 | 0 | 1 |
| Regulatory compliance among over-the-counter medicine sellers facilities within the Upper East Region of Ghana | 25.2 | 0 | 1 |
| ONiAd | 25.2 | 0 | 1 |
| Dentsu e3 Inc. | 25.2 | 0 | 1 |
| Fai Agency | 25.2 | 0 | 1 |
| Simon Clemmow | 25.2 | 0 | 1 |
| Reuveni Pridan | 25.2 | 0 | 1 |
| Facebook legal and regulatory advertising compliance by specialist orthodontic practices: a cross-sectional survey | 25.2 | 0 | 1 |
| Socioeconomic and Cost - Effective on Deforestation Compliancy Policies as Oppose to Pure Deterrence Model of Regulatory Compliance | 25.2 | 0 | 1 |
| Fostering Regulatory Compliance: The Role of Environmental Self-Auditing and Audit Policies | 25.2 | 0 | 1 |
| The planning and implementation process of Programmatic Advertising campaigns in emerging markets | 25.2 | 0 | 1 |
| Check My Ads | 25.2 | 0 | 1 |
| elbspot Werbeagentur | 25.2 | 0 | 1 |
| Publicis New York | 25.2 | 0 | 1 |
| ETO | 25.2 | 0 | 1 |
| Gamesight | 25.2 | 0 | 1 |
| The Impact of Regulatory Compliance on Agile Software Processes with a Focus on the FDA Guidelines for Medical Device Software | 25.2 | 0 | 1 |
| Avner Barel | 25.2 | 0 | 1 |
| thjnk | 25.2 | 0 | 1 |
| Lintas | 25.2 | 0 | 1 |
| Female Images In Poster Art of Advertising Agencies of the Art Nouveau Period | 25.2 | 0 | 1 |
| WEBMEDIARD | 25.2 | 0 | 1 |
| Toni Townes-Whitley | 25.2 | 0 | 1 |
| An IoT and Blockchain-based Approach for Ensuring Transparency and Accountability in Regulatory Compliance | 25.2 | 0 | 1 |
| Digitizing the Dollar: Privacy Considerations and Policy Prescriptions for a US Central Bank Digital Currency | 25.2 | 0 | 1 |
| A survey on the current status and future perspective of informed consent management in the MIRACUM consortium of the German Medical Informatics Initiative | 25.2 | 0 | 1 |
| 97/01966 Software use in a regulated industry | 25.2 | 0 | 1 |
| 97/00429 Software use in a regulated industry | 25.2 | 0 | 1 |
| David+Martin | 25.2 | 0 | 1 |
| advertising agencies | 25.2 | 0 | 1 |
| Ruthrauff & Ryan | 25.2 | 0 | 1 |
| advertising agency activities | 25.2 | 0 | 1 |
| Wexpid | 25.2 | 0 | 1 |
| CrowdMed-II: a blockchain-based framework for efficient consent management in health data sharing | 25.2 | 0 | 1 |
| Ad Age | 20.5 | 2 | 0 |
| KPMG | 20.5 | 2 | 0 |
| Forrester | 20.5 | 2 | 0 |
| Bloomberg Businessweek | 20.5 | 2 | 0 |
| Bloomberg Terminal | 20.5 | 2 | 0 |
| 360i | 20.5 | 2 | 0 |
| Florida State University Law Review | 20.5 | 2 | 0 |
| HubSpot | 20.5 | 2 | 0 |
| Journal of Land Use and Environmental Law | 20.5 | 2 | 0 |
| Journal of Transnational Law & Policy | 20.5 | 2 | 0 |
| Quarry Integrated Communications | 20.5 | 2 | 0 |
| Column Five | 20.5 | 2 | 0 |
| Smaato | 20.5 | 2 | 0 |
| Hubstaff | 20.5 | 2 | 0 |
| Forbes 30 Under 30 | 20.5 | 2 | 0 |
| CaosDB - Research Data Management for Complex, Changing, and Automated Research Workflows | 20.5 | 2 | 0 |
| bidirectional encoder representations from transformers | 20.5 | 2 | 0 |
| NASDAQ/Ngs (Global Select Market) | 20.5 | 2 | 0 |
| OMD Worldwide | 20.5 | 2 | 0 |
| CB Insights | 20.5 | 2 | 0 |
| The David Rubenstein Show | 20.5 | 2 | 0 |
| Bloomberg Bpool | 20.5 | 2 | 0 |
| Hubstaff | 20.5 | 2 | 0 |
| SPARQL Generation: an analysis on fine-tuning OpenLLaMA for Question Answering over a Life Science Knowledge Graph | 20.5 | 2 | 0 |
| Forbes ASAP | 20.5 | 2 | 0 |
| Forbes Best-In-State Wealth Advisor | 20.5 | 2 | 0 |
| Forbes Top 250 Wealth Advisor | 20.5 | 2 | 0 |
| Bipartisan Patient Protection Act of 2001 | 20.5 | 2 | 0 |
| Anove International | 20.5 | 2 | 0 |
| United States Congress | 12.9 | 1 | 0 |
| Bloomberg Television | 12.9 | 1 | 0 |
| Bloomberg L.P. | 12.9 | 1 | 0 |
| Nasdaq | 12.9 | 1 | 0 |
| arXiv | 12.9 | 1 | 0 |
| Gartner | 12.9 | 1 | 0 |
| IQVIA Holdings, Inc. | 12.9 | 1 | 0 |
| Accenture | 12.9 | 1 | 0 |
| PR Newswire | 12.9 | 1 | 0 |
| The World's Billionaires | 12.9 | 1 | 0 |
| Nasdaq-100 | 12.9 | 1 | 0 |
| Havas | 12.9 | 1 | 0 |
| Bloomberg Markets | 12.9 | 1 | 0 |
| The Princeton Review | 12.9 | 1 | 0 |
| Forbes | 12.9 | 1 | 0 |
| The World's Most Powerful People | 12.9 | 1 | 0 |
| Forbes Global 2000 | 12.9 | 1 | 0 |
| WPP plc | 12.9 | 1 | 0 |
| Fast Company | 12.9 | 1 | 0 |
| Mike Lazaridis | 12.9 | 1 | 0 |
| Mindshare | 12.9 | 1 | 0 |
| Interpublic Group of Companies | 12.9 | 1 | 0 |
| Omnicom Group | 12.9 | 1 | 0 |
| Publicis | 12.9 | 1 | 0 |
| IQVIA | 12.9 | 1 | 0 |
| Publicis Sapient | 12.9 | 1 | 0 |
| Polaris | 12.9 | 1 | 0 |
| Forbes 400 | 12.9 | 1 | 0 |
| VeriFone | 12.9 | 1 | 0 |
| Mitsubishi Chemical Holdings | 12.9 | 1 | 0 |
| Havas Media | 12.9 | 1 | 0 |
| HighBeam Research | 12.9 | 1 | 0 |
| Hill & Knowlton | 12.9 | 1 | 0 |
| Razorfish | 12.9 | 1 | 0 |
| Q3500208 | 12.9 | 1 | 0 |
| 1-800-FREE-411 | 12.9 | 1 | 0 |
| BASIS International | 12.9 | 1 | 0 |
| Bloomberg Technology | 12.9 | 1 | 0 |
| Brandwatch | 12.9 | 1 | 0 |
| Brian Halligan | 12.9 | 1 | 0 |
| Caribbean Law Institute | 12.9 | 1 | 0 |
| Congressional Record | 12.9 | 1 | 0 |
| Digitas | 12.9 | 1 | 0 |
| Eric Mower and Associates | 12.9 | 1 | 0 |
| FINS.com | 12.9 | 1 | 0 |
| Florida State University College of Law | 12.9 | 1 | 0 |
| Global Warming Pollution Reduction Act of 2007 | 12.9 | 1 | 0 |
| GovTrack | 12.9 | 1 | 0 |
| GroupM | 12.9 | 1 | 0 |
| kayak.com | 12.9 | 1 | 0 |
| Marin Software | 12.9 | 1 | 0 |
| Mediaocean | 12.9 | 1 | 0 |
| National Association of Attorneys General | 12.9 | 1 | 0 |
| Performics | 12.9 | 1 | 0 |
| Red Ventures | 12.9 | 1 | 0 |
| TransUnion | 12.9 | 1 | 0 |
| Vantage media | 12.9 | 1 | 0 |
| WDCH-FM | 12.9 | 1 | 0 |
| ZoomInfo | 12.9 | 1 | 0 |
| Crunchbase | 12.9 | 1 | 0 |
| Accenture Technology Solutions Japan | 12.9 | 1 | 0 |
| Forbes' list of the world's highest-paid athletes | 12.9 | 1 | 0 |
| KPMG Azsa LLC | 12.9 | 1 | 0 |
| Bloomberg News | 12.9 | 1 | 0 |
| Thryv, Inc. | 12.9 | 1 | 0 |
| Vance McAllister | 12.9 | 1 | 0 |
| Pediatric Annals | 12.9 | 1 | 0 |
| Journal of Psychosocial Nursing and Mental Health Services | 12.9 | 1 | 0 |
| Journal of Refractive Surgery | 12.9 | 1 | 0 |
| Journal of Pediatric Ophthalmology and Strabismus | 12.9 | 1 | 0 |
| Nephrology News and Issues: balancing economics and quality in renal care | 12.9 | 1 | 0 |
| Mohamed Mansour | 12.9 | 1 | 0 |
| Mark Beech | 12.9 | 1 | 0 |
| republica.com | 12.9 | 1 | 0 |
| Demandbase | 12.9 | 1 | 0 |
| PitchBook Data | 12.9 | 1 | 0 |
| Klick Health | 12.9 | 1 | 0 |
| Optimizely | 12.9 | 1 | 0 |
| Marchex | 12.9 | 1 | 0 |
| Sprout Social | 12.9 | 1 | 0 |
| Tenthwave Digital | 12.9 | 1 | 0 |
| Tobacco Master Settlement Agreement | 12.9 | 1 | 0 |
| Q17651675 | 12.9 | 1 | 0 |
| Tealium | 12.9 | 1 | 0 |
| Polaris Slingshot | 12.9 | 1 | 0 |
| Three UK | 12.9 | 1 | 0 |
| Conductor | 12.9 | 1 | 0 |
| MediaPost | 12.9 | 1 | 0 |
| Advertising Week OMMA Awards | 12.9 | 1 | 0 |
| Veeva Systems | 12.9 | 1 | 0 |
| Forbes | 12.9 | 1 | 0 |
| Eye to Eye | 12.9 | 1 | 0 |
| High Flyers | 12.9 | 1 | 0 |
| iCrossing | 12.9 | 1 | 0 |
| Xaxis | 12.9 | 1 | 0 |
| Orthopedics | 12.9 | 1 | 0 |
| American Demographics | 12.9 | 1 | 0 |
| The journal of speech and language pathology, applied behavior analysis | 12.9 | 1 | 0 |
| Ophthalmic Surgery, Lasers & Imaging Retina | 12.9 | 1 | 0 |
| Q28126601 | 12.9 | 1 | 0 |
| 21st Century Cures Act | 12.9 | 1 | 0 |
| Michael D’Antonio | 12.9 | 1 | 0 |
| American Health Care Act | 12.9 | 1 | 0 |
| Cardinal Path | 12.9 | 1 | 0 |
| Accenture (Spain) | 12.9 | 1 | 0 |
| Accenture (United States) | 12.9 | 1 | 0 |
| H.R.3819; 108th Congress | 12.9 | 1 | 0 |
| Accenture (Norway) | 12.9 | 1 | 0 |
| Accenture (United Kingdom) | 12.9 | 1 | 0 |
| Accenture (Switzerland) | 12.9 | 1 | 0 |
| Accenture (Sweden) | 12.9 | 1 | 0 |
| Essence Global | 12.9 | 1 | 0 |
| Bloomberg Billionaires Index | 12.9 | 1 | 0 |
| Intouch Solutions | 12.9 | 1 | 0 |
| Finn Partners (United States) | 12.9 | 1 | 0 |
| Digiday | 12.9 | 1 | 0 |
| FER+ | 12.9 | 1 | 0 |
| Human Interaction Network Ontology | 12.9 | 1 | 0 |
| Ontology of Social Participation | 12.9 | 1 | 0 |
| IQVIA (India) | 12.9 | 1 | 0 |
| Shimon Haber | 12.9 | 1 | 0 |
| Q60171061 | 12.9 | 1 | 0 |
| Journal of Gerontological Nursing | 12.9 | 1 | 0 |
| Psychiatric Annals | 12.9 | 1 | 0 |
| Q67836148 | 12.9 | 1 | 0 |
| Quantum correlations in multi-qubit-cavity systems | 12.9 | 1 | 0 |
| Secure Access Service Edge | 12.9 | 1 | 0 |
| Q86068569 | 12.9 | 1 | 0 |
| Quicktake | 12.9 | 1 | 0 |
| T5 | 12.9 | 1 | 0 |
| Kenshoo | 12.9 | 1 | 0 |
| Think With Google Podcast | 12.9 | 1 | 0 |
| Bloomberg Trading Facility Limited | 12.9 | 1 | 0 |
| Bloomberg - APA | 12.9 | 1 | 0 |
| GPT-3 | 12.9 | 1 | 0 |
| Health literacy research and practice | 12.9 | 1 | 0 |
| StyleGAN | 12.9 | 1 | 0 |
| Annals of International Occupational Therapy | 12.9 | 1 | 0 |
| Computing Research Repository | 12.9 | 1 | 0 |
| Campaign Monitor | 12.9 | 1 | 0 |
| New Books Show How Trolls And Extremists Won The Presidency For Donald Trump | 12.9 | 1 | 0 |
| Republic Bangla | 12.9 | 1 | 0 |
| NSDQ Dark | 12.9 | 1 | 0 |
| NASDAQ Capital Market | 12.9 | 1 | 0 |
| NASDAQ Options Market | 12.9 | 1 | 0 |
| NASDAQ Intermarket | 12.9 | 1 | 0 |
| NASDAQ/NMS (Global Market) | 12.9 | 1 | 0 |
| Nasdaq Fixed Income Trading | 12.9 | 1 | 0 |
| Nasdaq Commodities - EUR Power/Energy | 12.9 | 1 | 0 |
| Nasdaq Commodities - SEK Power/Energy | 12.9 | 1 | 0 |
| Nasdaq Commodities - NOK Power/Energy | 12.9 | 1 | 0 |
| efficientnet | 12.9 | 1 | 0 |
| bert-tensorflow | 12.9 | 1 | 0 |
| Accenture (Germany) | 12.9 | 1 | 0 |
| Averting Loss of Life and Injury by Expediting SIVs Act of 2021 | 12.9 | 1 | 0 |
| Road Roughness Estimation Using Machine Learning | 12.9 | 1 | 0 |
| The Bloomberg Cubid 19 Immunity Index | 12.9 | 1 | 0 |
| Hubstaff Time | 12.9 | 1 | 0 |
| Hubstaff Desk | 12.9 | 1 | 0 |
| Hubstaff Field | 12.9 | 1 | 0 |
| Hubstaff Tasks | 12.9 | 1 | 0 |
| I Love Wine | 12.9 | 1 | 0 |
| Multimodal registration of FISH and nanoSIMS images using convolutional neural network models | 12.9 | 1 | 0 |
| Restoring Execution Environments of Jupyter Notebooks | 12.9 | 1 | 0 |
| Machine Learning and Deep Learning -- A review for Ecologists | 12.9 | 1 | 0 |
| How can NLP Help Revitalize Endangered Languages? A Case Study and Roadmap for the Cherokee Language | 12.9 | 1 | 0 |
| End-to-End Relation Extraction using LSTMs on Sequences and Tree Structures | 12.9 | 1 | 0 |
| GitRanking: A Ranking of GitHub Topics for Software Classification using Active Sampling | 12.9 | 1 | 0 |
| Bloomberg.com | 12.9 | 1 | 0 |
| Structured references from PDF articles: assessing the tools for bibliographic reference extraction and parsing | 12.9 | 1 | 0 |